Cite

HARVARD Citation

    Beksac, M. et al. (2022). Evaluation of isatuximab in patients with soft-tissue plasmacytomas: An analysis from ICARIA-MM and IKEMA. Leukemia research. p. . [Online]. 
  
Back to record